pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-873 |
Genomic Coordinates | chr9: 28888879 - 28888955 |
Synonyms | MIRN873, hsa-mir-873, MIR873 |
Description | Homo sapiens miR-873 stem-loop |
Comment | This sequence was identified as a miRNA candidate by Berezikov et al. using RAKE and MPSS techniques . |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-873-3p | |||||||||||||||||||||
Sequence | 46| GGAGACUGAUGAGUUCCCGGGA |67 | |||||||||||||||||||||
Evidence | Not_experimental | |||||||||||||||||||||
Experiments | ||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TMED7 | ||||||||||||||||||||
Synonyms | CGI-109, p24g3, p24gamma3, p27 | ||||||||||||||||||||
Description | transmembrane p24 trafficking protein 7 | ||||||||||||||||||||
Transcript | NM_181836 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TMED7 | |||||||||||||||||||||
3'UTR of TMED7 (miRNA target sites are highlighted) |
>TMED7|NM_181836|3'UTR 1 CTACGTTTTGAGAATTGATGCACCATTGCCACTGTAATATTGCTGTCCTCTAATTAATTTTAGGTACTGAAGAACTTAAT 81 ATTGGCAACATTTTTAAATCCTTACTCATACACTTGTTGGGAGGGATGTACAATGCATATTCCCAAACTGTGGAAAGGAC 161 ACCTTTTTTTATTTGTAAAGGTGGAAAAACTTTGGAACTCATTTTGGGCTATTCATGTTAAATATTCAACACCAATGATC 241 TACTCTGTTCGCAGTTGTTTATATCTACTCTTCGCACACTAAACTTTGGTATTTTGATTCCTTTTAACCATTTAAGACTA 321 CTTTTCTTATAGGTAGTTGATATTTTAAAAACTTTAGATTTAATGTCTACATGTGTTAGGGAGGAAGAAAATTGCCTTTT 401 AATTGTTAATAAGAAAACCAAATGTGATGAACTGTAGCCCAAGCCCTATTCTGCACTGTTCAGTTTTATGGAGGAAAAAT 481 AAATCTACCATAGGAATGTTAGTTAATATTGATATATCATGGTAAAATTGATTTCTCACTAGCTTAGAAAATGTCAGACT 561 TTTGTTTTTGGGGTTTATAATTTAAACCAGCTATGCTATTTTTTCATAAAGGCATTTGTAGTACACAGAAAACAGTAGTT 641 TCAGTAGTGTAAAAGAGTTTATACAGGCCTTAAATATCAGACTTTGTAACAGGTAGAAATATTACAGAATAATTTAAGAC 721 ACTACAATGGGGGCAAATGAAATAGGAAAATTTTTAGTGAGTTACACGTACTCATTACATTTTCAGTGCTTTTACAAGGA 801 AAAAAGGTGATATGTTTAATTTTAAAATTTTAATTGGCTAGCTCTTGCCCTTATATGACTTTAATGTCTGTGAGTCATTC 881 CCAGCTTAAATTAACAATTGTTAGTATTAGTCTCACACATAAGTGCCATACATTTTATCCTCATGGATGTGATGCACTGA 961 AAAGTTAGTTGCTCTCCTTTTTTCTTTTTTTTGTCGTGCATATTTTATTTCTGTAGTTTCTGGTTAGCTACCCTAAAGTG 1041 ATTTAAAAATTTAGAATGCTTTGTGTTTCCTATTTGGTAATCTTCATTGACTTTTCTTTAGTTAATGAGTATTAAATAGT 1121 GCATATTCTGTAGACTATAGGGTTTACATTGTGTTGCATCTTATAACTTGTATAGATTGAGCTGATTGAAATAAGATTTT 1201 GTTCCAAGTATTATCTGATAGAATACAAGATGATTCAAAATTATATAGATATTTAAAGCTTTTCTGCTGTTTTTTTTTTT 1281 TTTAATTGCAACTGCTTTTCTGCCGTGCCTCTCTTCCCTACCCAAAAGTGATGAGTTCTGAACAAGACAAGACTGTCATA 1361 TTGTAGAGACTTTGGTATGTGATACCATAGAATACTGATTGGATAGCCATCCTAGTCACTTACCAATACTGACTAGAAGT 1441 TAACTCTTAATTCTAAGCTATCTTAAAATGCATATATATACTTCTTGCATGGAAGAGCAAAACAAATTCAAGTTGTCATG 1521 CCTGATAATTTCAGATGCCACCGTATAGCAAAGGGTGAACATGTTTTCAACCCTTTAACTTTTTACGGTGTTTGAAGACC 1601 AGCTACTCCTTAATATTTATCAATGGATTAAGAAGTTTAAGATTTTGCAGATTTATCAATTTGGGTTTTTGTACTGAAGT 1681 TGTCTTGCGGCTTTGCAAGTGTCCCTTTATATTTAAATTTGAAAGTTGTAAGCACTGATGTTAATGTGATTGATCAGCAT 1761 GGGCATATGTAAAATGTCCTTTTCTGGTTGCCTCTCTATGCTATTGTGTTCAGATACTTACACCATAATTAAACAGTAAG 1841 TTATAGACTTGCTGAGTTTGGCATAGATAGTGCACTCATTTAATCTGTGCCTCTCAAAACTTCAGAATATTAGCATATTA 1921 CCACAAATAATTTTTGGTGAAACTATTGAGATATTAAAATTTTTGAAATCACTACTGTTACCTGTTATAGAAAATAGTGT 2001 TGGCTTAGTCTAGTCTCTGTGTAACTGGTTACATTTTGATGGTTGTCTATACTCAACTGGATATGTGTATGTAAATTAGA 2081 AAATACATACCTATCCAGACATAAATGCTAAGTAACATTTTTTTCTTCCTCCAACTACATAATTTGTAGCTCATCATTTT 2161 TCCTTAATCCTTTCCTAACTTGTTGCAGCAGTTTGAATTTCCCAGATATTTATGTTTGAACATAATGGCTCAGAATACAT 2241 ATTTGAACATCATAGTTGTATATATTTTTAAAGTAGAATAAATAATGGAAAGCAACTTGATATACAAGTTTATACTAAAA 2321 TTTCAACTGTGTGAAGATACATTTTAAGGCATTACTTTGCTAATAATCTACACATTCTTTTTTCTATTAAATAAACAAAT 2401 GGTTTGTGGTTCACAGCTTTCATCCAAGCTTGGTGATAATCAATTTTGAAAATACAGTGGACTGAAAAGCAAATTTATTC 2481 TTTCGAAGATTTCATTTAAATCTCTGTACTATGCATTTTTGTTTCAGTTTGTAAATGTGTAACATTTATAGTTAAATAGG 2561 ACAAAGCAGGCCCTATGACTATTGTTTTCAAAAAATTAATATATAAATAATTCAGAGGGGTTTTTCATTTACTTTTGAAA 2641 AGAAATTTCTTTAACAGGATTGCACCTATCAATTTCTTGTAGAATAAAAAAAAATCTTTCAACAAACTGACTTTACTTGT 2721 TTCTGTCAGGATTTAAATCTTTCTAAAGCTCCTTATAAACTTAAAGCCTAGAGTACAGTTCTGTAATGAGAGTGATTATT 2801 TATTTGGTATTTTATTAAAATATCTGAGGGACTGTCCAAGAAAGAAGGTGAAAGAGAAATACCACGTCTGTACTGCCTAA 2881 TTTGTAACCTTCTCTTTGCATTCCTTACTGAAAGTTTGTGTAGGTGAAAAGCAGTTAAATCATCAGTTGCTCTAAAGAGG 2961 TCTTAATTTTTAAGTAAATTACCTTTAGTTTGTATATTACC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 51014.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000456936.3 | 3UTR | UCUCACACAUAAGUGCCAUACAUUUUAUCCUCAUGGAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000456936.3 | 3UTR | UCUCACACAUAAGUGCCAUACAUUUUAUCCUCAUGGAUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
108 hsa-miR-873-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT081178 | MIDN | midnolin | ![]() |
![]() |
2 | 4 | ||||||
MIRT109809 | ZFX | zinc finger protein, X-linked | ![]() |
![]() |
2 | 4 | ||||||
MIRT242383 | TMC5 | transmembrane channel like 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT444003 | METRN | meteorin, glial cell differentiation regulator | ![]() |
![]() |
2 | 4 | ||||||
MIRT444097 | SEPHS1 | selenophosphate synthetase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446158 | RPL12 | ribosomal protein L12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446859 | SAMD9L | sterile alpha motif domain containing 9 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT447275 | FZD5 | frizzled class receptor 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447391 | TMPRSS15 | transmembrane protease, serine 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448817 | FKBP1A | FK506 binding protein 1A | ![]() |
![]() |
2 | 4 | ||||||
MIRT450582 | HIST1H2BG | histone cluster 1 H2B family member g | ![]() |
![]() |
2 | 2 | ||||||
MIRT451776 | USP36 | ubiquitin specific peptidase 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457961 | ABCC5 | ATP binding cassette subfamily C member 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT458424 | KLHL38 | kelch like family member 38 | ![]() |
![]() |
2 | 4 | ||||||
MIRT461383 | SLFN12L | schlafen family member 12 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT467793 | SLC2A14 | solute carrier family 2 member 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476517 | GABRB1 | gamma-aminobutyric acid type A receptor beta1 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT480290 | C7orf73 | short transmembrane mitochondrial protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT482745 | HES7 | hes family bHLH transcription factor 7 | ![]() |
![]() |
2 | 10 | ||||||
MIRT483189 | HIST1H2AH | histone cluster 1 H2A family member h | ![]() |
![]() |
2 | 6 | ||||||
MIRT486545 | DCTN4 | dynactin subunit 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT486581 | ZNF619 | zinc finger protein 619 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492604 | POLR3E | RNA polymerase III subunit E | ![]() |
![]() |
2 | 2 | ||||||
MIRT494130 | DCAF7 | DDB1 and CUL4 associated factor 7 | ![]() |
![]() |
2 | 6 | ||||||
MIRT496023 | ZBED3 | zinc finger BED-type containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497121 | NBEAL1 | neurobeachin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497400 | TMEM245 | transmembrane protein 245 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501410 | RANBP10 | RAN binding protein 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT510947 | PPTC7 | PTC7 protein phosphatase homolog | ![]() |
![]() |
2 | 6 | ||||||
MIRT512494 | ARID2 | AT-rich interaction domain 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT512595 | ZNF783 | zinc finger family member 783 | ![]() |
![]() |
2 | 2 | ||||||
MIRT512612 | CNTN4 | contactin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517808 | UGDH | UDP-glucose 6-dehydrogenase | ![]() |
![]() |
2 | 6 | ||||||
MIRT520686 | TMED7 | transmembrane p24 trafficking protein 7 | ![]() |
![]() |
2 | 4 | ||||||
MIRT526179 | HEPH | hephaestin | ![]() |
![]() |
2 | 2 | ||||||
MIRT532568 | CSTF1 | cleavage stimulation factor subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533979 | TADA2A | transcriptional adaptor 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT538622 | CCSER2 | coiled-coil serine rich protein 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT539703 | EIF3H | eukaryotic translation initiation factor 3 subunit H | ![]() |
![]() |
2 | 2 | ||||||
MIRT539806 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540422 | FAM83F | family with sequence similarity 83 member F | ![]() |
![]() |
2 | 2 | ||||||
MIRT540506 | CXCL10 | C-X-C motif chemokine ligand 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540619 | F2RL2 | coagulation factor II thrombin receptor like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT542423 | ZNF331 | zinc finger protein 331 | ![]() |
![]() |
2 | 2 | ||||||
MIRT542454 | AKR7A2 | aldo-keto reductase family 7 member A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT543383 | CC2D2A | coiled-coil and C2 domain containing 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT544777 | CSTF2T | cleavage stimulation factor subunit 2 tau variant | ![]() |
![]() |
2 | 4 | ||||||
MIRT544923 | ERCC4 | ERCC excision repair 4, endonuclease catalytic subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT549768 | ZNF611 | zinc finger protein 611 | ![]() |
![]() |
2 | 4 | ||||||
MIRT551242 | COLEC10 | collectin subfamily member 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560474 | ENSA | endosulfine alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT569738 | GPR173 | G protein-coupled receptor 173 | ![]() |
![]() |
2 | 2 | ||||||
MIRT571297 | CHCHD4 | coiled-coil-helix-coiled-coil-helix domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572345 | CKAP2L | cytoskeleton associated protein 2 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT573112 | ERBB2IP | erbb2 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT607744 | ANGPT4 | angiopoietin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607903 | SPRYD4 | SPRY domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611744 | SERPING1 | serpin family G member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT615101 | BNC2 | basonuclin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619124 | CD40LG | CD40 ligand | ![]() |
![]() |
2 | 2 | ||||||
MIRT625572 | ANKRD42 | ankyrin repeat domain 42 | ![]() |
![]() |
2 | 2 | ||||||
MIRT629038 | KLLN | killin, p53-regulated DNA replication inhibitor | ![]() |
![]() |
2 | 2 | ||||||
MIRT633986 | SLC35E2 | solute carrier family 35 member E2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT635675 | COX18 | COX18, cytochrome c oxidase assembly factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT637471 | DEFB105B | defensin beta 105B | ![]() |
![]() |
2 | 4 | ||||||
MIRT637503 | DEFB105A | defensin beta 105A | ![]() |
![]() |
2 | 4 | ||||||
MIRT639735 | MAP2K2 | mitogen-activated protein kinase kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640730 | C9orf64 | chromosome 9 open reading frame 64 | ![]() |
![]() |
2 | 2 | ||||||
MIRT645364 | C9orf47 | chromosome 9 open reading frame 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647938 | RNF152 | ring finger protein 152 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649400 | SH2D4A | SH2 domain containing 4A | ![]() |
![]() |
2 | 2 | ||||||
MIRT656860 | KIN | Kin17 DNA and RNA binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT663470 | POFUT2 | protein O-fucosyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663507 | NKAPL | NFKB activating protein like | ![]() |
![]() |
2 | 4 | ||||||
MIRT667690 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT677403 | PCNP | PEST proteolytic signal containing nuclear protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT678682 | SCUBE3 | signal peptide, CUB domain and EGF like domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678789 | NUPL2 | nucleoporin like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT680649 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 2 | ||||||
MIRT682450 | MTX3 | metaxin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT682740 | CA6 | carbonic anhydrase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684421 | TUFT1 | tuftelin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690535 | TRAPPC2 | trafficking protein particle complex 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690595 | C17orf105 | chromosome 17 open reading frame 105 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690771 | PLA2G2C | phospholipase A2 group IIC | ![]() |
![]() |
2 | 2 | ||||||
MIRT692233 | ALDH1B1 | aldehyde dehydrogenase 1 family member B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT693667 | MXRA7 | matrix remodeling associated 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695551 | CLPB | ClpB homolog, mitochondrial AAA ATPase chaperonin | ![]() |
![]() |
2 | 2 | ||||||
MIRT695870 | C19orf52 | translocase of inner mitochondrial membrane 29 | ![]() |
![]() |
2 | 2 | ||||||
MIRT696214 | LYZ | lysozyme | ![]() |
![]() |
2 | 2 | ||||||
MIRT698368 | TMED4 | transmembrane p24 trafficking protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT700795 | PHTF2 | putative homeodomain transcription factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT701640 | MYLK3 | myosin light chain kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702989 | HERPUD2 | HERPUD family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703627 | FBXL3 | F-box and leucine rich repeat protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703783 | FAM102B | family with sequence similarity 102 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT704293 | DDX19B | DEAD-box helicase 19B | ![]() |
![]() |
2 | 2 | ||||||
MIRT704828 | CDC73 | cell division cycle 73 | ![]() |
![]() |
2 | 2 | ||||||
MIRT705014 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708480 | OLR1 | oxidized low density lipoprotein receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710770 | PHF7 | PHD finger protein 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718918 | TRIM66 | tripartite motif containing 66 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720390 | ZNF549 | zinc finger protein 549 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720593 | TTC39C | tetratricopeptide repeat domain 39C | ![]() |
![]() |
2 | 2 | ||||||
MIRT723515 | SIGLEC8 | sialic acid binding Ig like lectin 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724458 | PRKX | protein kinase, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT737267 | UMAD1 | UBAP1-MVB12-associated (UMA) domain containing 1 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737356 | ZIC2 | Zic family member 2 | ![]() |
![]() |
![]() |
![]() |
4 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|